Literature DB >> 1519231

Recurrent venous thrombosis during warfarin treatment related to acquired protein S deficiency.

O R Odegaard1, A K Lindahl, K Try, G Kvalheim, J H Sørbø.   

Abstract

Failure of warfarin to prevent new thrombotic processes was observed in three patients with very low free protein S concentrations and high C4b-binding protein (C4bBP) concentrations, and in one patient with hereditary protein S deficiency. We suggest that an increase in C4bBP reduces the free Protein S level, and warfarin treatment causes an additional decrease of free protein S. The four patients presented indicate that such reductions are of clinical importance. Heparin seems preferable as an anticoagulant in this situation, as warfarin given alone is ineffective, or may even be harmful. In a group of pancreatic cancer patients with advanced disease, subnormal mean free protein S was found, whereas mean total protein S concentration, and mean C4bBP concentrations were significantly higher (p less than 0.01) than in healthy controls. These findings indicate that an increase in C4bBP may induce free protein S deficiency contributing to the increased thrombotic tendency in this group of patients. The correlation between free protein S and C4bBP was 0.11, (n.s.), between total protein S and C4bBP 0.73 (p less than 0.0001).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1519231     DOI: 10.1016/0049-3848(92)90048-f

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  3 in total

1.  Persistence and Discontinuation of Oral Anticoagulant: Remaining Issues Not Addressed by Phase III Clinical Trials.

Authors:  Kengo Ayabe; Shinichi Goto; Shinya Goto
Journal:  J Am Heart Assoc       Date:  2016-02-23       Impact factor: 5.501

Review 2.  Targeting Gas6/TAM in cancer cells and tumor microenvironment.

Authors:  Guiling Wu; Zhiqiang Ma; Yicheng Cheng; Wei Hu; Chao Deng; Shuai Jiang; Tian Li; Fulin Chen; Yang Yang
Journal:  Mol Cancer       Date:  2018-01-31       Impact factor: 27.401

3.  Rivaroxaban Treatment for Warfarin-Refractory Thrombosis in a Patient with Hereditary Protein S Deficiency.

Authors:  Koken Ameku; Mariko Higa
Journal:  Case Rep Hematol       Date:  2018-01-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.